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Diameters of microvessels undergo continuous structural adaptation in response to
hemodynamic and metabolic stimuli. To ensure adequate flow distribution, metabolic
responses are needed to increase diameters of vessels feeding poorly perfused regions.
Possible modes of metabolic control include release of signaling substances from vessel
walls, from the supplied tissue and from red blood cells (RBC). Here, a theoretical model
was used to compare the abilities of these metabolic control modes to provide adequate
tissue oxygenation, and to generate blood flow velocities in agreement with experimental
observations. Structural adaptation of vessel diameters was simulated for an observed
mesenteric network structure in the rat with 576 vessel segments. For each mode of
metabolic control, resulting distributions of oxygen and deviations between simulated
and experimentally observed flow velocities were analyzed. It was found that wall-derived
and tissue-derived growth signals released in response to low oxygen levels could
ensure adequate oxygen supply, but RBC-derived signals caused inefficient oxygenation.
Closest agreement between predicted and observed flow velocities was obtained with
wall-derived growth signals proportional to vessel length. Adaptation in response to
oxygen-independent release of a metabolic signal substance from vessel walls or the
supplied tissue was also shown to be effective for ensuring tissue oxygenation due to
a dilution effect if growth signal substances are released into the blood. The present
results suggest that metabolic signals responsible for structural adaptation of microvessel
diameters are derived from vessel walls or from perivascular tissue.
Keywords: blood flow, microcirculation, oxygen transport, structural adaptation, vascular remodeling
INTRODUCTION
Structural adaptation (remodeling) of vessel luminal diameters is indispensable for generation and
maintenance of functionally adequate microvascular networks. The structural diameter of a vessel
is here defined as the internal diameter at a physiological transmural pressure in the absence of
vascular tone. Under normal conditions, vessel diameters are determined by the structural diameter
combined with any effects of smooth muscle cell tone. Several stimuli for structural diameter
changes have been identified, including circumferential stress in the vascular wall, shear stress
on the endothelial cell surface, local metabolic conditions and conducted responses propagated
along vessel walls (Pries et al., 1998). Theoretical studies have shown that diameter adaptation
in response to wall shear stress alone causes regression of complex network structures to single
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arterio-venous pathways (Rodbard, 1975; Hacking et al.,
1996). This instability originates from a positive feedback
mechanism: Vessels with higher blood flow experience higher
wall shear stress, evoking a stimulus for diameter increase,
which leads to further increase of blood flow (Figure 1A). Thus,
a compensatory negative feedback mechanism is needed to
maintain blood flow and to preserve parallel flow pathways.
Such a negative feedback can be derived from local metabolic
conditions, if low local blood flow or an imbalance between
substrate supply and demand causes the generation of a
signal for diameter increase (Figure 1A). Oxygen is a critical
metabolite, and the metabolic signal is often assumed to be
related to the local oxygen level. According to this concept,
decreased oxygen partial pressures (PO2) induce increased
release of metabolic signaling substance(s) which evokes
structural increases of vessel diameters, increasing perfusion and
restoring adequate PO2 values. Alternatively, decreased PO2 may
induce decreased release of (vasoconstrictive) substances evoking
diameter decrease.
Experimental studies of acute blood flow regulation have
established the role of metabolic mechanisms in controlling
diameters of arterioles and small arteries via changes of smooth
muscle tone. These studies provide evidence for different sites of
oxygen-dependent release of vasoactive substances, specifically
the parenchymal tissue, the red blood cells (RBCs), and the
vessel wall (Figure 1B). It has also been suggested that increasing
PO2 may lead to increased release of vasoconstrictive mediators
(Jackson, 1993; Lombard et al., 1999). As mediators of metabolic
vasodilator signaling by the parenchymal tissue, substances
including adenosine, CO2, O
−
2 , phosphates, prostanoids and
osmolality have been suggested (Berne, 1963; Broten et al., 1991;
Golub and Pittman, 2013). RBCs were shown to deliver ATP
from intracellular pools in response to the local saturation of
hemoglobin with oxygen (Bergfeld and Forrester, 1992; Ellsworth
et al., 1995). Additionally, nitric oxide (NO) as a metabolic signal
substance is liberated from S-nitrosohemoglobin in proportion
to the decline of hemoglobin saturation along a vessel (Jia
et al., 1996; Stamler et al., 1997) or reduced from nitrite
mediated by deoxyhemoglobin (Cosby et al., 2003; Nagababu
et al., 2003). Possible metabolic signal substances released by the
vessel wall or its immediately adjacent tissues include adenosine,
NO, prostaglandins and endothelium-derived hyperpolarizing
factor (Busse et al., 1983; Pohl and Busse, 1989; Messina et al.,
1994; Earley et al., 2003). Several studies have shown that
chronic vasoconstriction or vasodilation leads to corresponding
structural changes in vessel diameter (Bakker et al., 2004;
Jacobsen et al., 2008; Martinez-Lemus et al., 2009). Therefore, the
various factors that have been proposed as contributing to acute
flow regulation can also be considered as potential mediators of
structural adaptation of vessel diameters.
While these studies have suggested potential mechanisms
of metabolic signaling in structural adaptation, the relevance
of these mechanisms and how they are integrated to achieve
adequate diameter control remain to be determined. Therefore,
the goal of the present study is to test several possible modes
for metabolic structural control of vessel diameters, with respect
to their ability to provide adequate tissue oxygenation and to
FIGURE 1 | Concepts of metabolic signaling in vessel diameter adaptation.
(A) Feedback loops in structural control of vessel diameters. Arrows and blunt
ends indicate stimulatory and inhibitory actions respectively. Signs “+” and “–”
in gray rectangles indicate positive and negative feedback regulation. Upper
loop: an increase in vessel diameter causes an increase in blood flow and wall
shear stress, which stimulates structural diameter increase. This positive
feedback loop tends to destabilize vessel diameters. Lower loop: an increase
in vessel diameter causes an increase in flow and improved tissue
oxygenation. The resulting reduction in metabolic signal substance production
evoking diameter increase causes structural diameter decrease. This negative
feedback loop tends to stabilize vessel diameters. (B) Possible origins of
metabolic signals. Local oxygen levels have been shown to evoke release of
metabolic signal substances (solid arrows) from the vessel wall, from RBCs
and/or from tissue cells. Dashed arrows indicate oxygen diffusion.
generate blood flow velocities in agreement with experimental
observations. A previously developed theoretical model (Reglin
et al., 2009) is used to simulate vessel diameter adaptation
in response to hemodynamic and metabolic stimuli for a rat
mesentery microvascular network with 576 vessel segments
where complete morphological and hemodynamic data sets were
previously obtained from in vivo observations. By incorporating
various assumed modes of metabolic control in the model,
the effects of these control modes on network structure, flow
and oxygenation were assessed. The tested modes include
vessel-derived, tissue-derived and RBC-derived metabolic signals
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acting individually and in combination and oxygen-dependent
and oxygen-independent generation of these signals.
MATERIALS AND METHODS
Experimental Data
Details of the approach have been described previously (Pries,
1988). After approval by the University and State authorities
for animal welfare, surgical and experimental procedures were
carried out in accordance with the German Animal Protection
Act. A microvascular network (total area ∼25 mm2) of a male
Wistar rat (∼300 g body weight) in a fat-free and lymph
vessel-free portion of the mesentery was recorded by intravital
video microscopy in a scanning procedure lasting ∼20min.
Upon finishing the experiment, the animal was sacrificed by
an overdose of pentobarbital. The mesentery membrane is a
relatively simple flat tissue, lacking some of the features of
more complex parenchymal organs. However, it is reasonable
to assume that a similar set of basic adaptation mechanisms
is present in other tissues. Independent experiments with this
preparation showed that arterioles exhibited no spontaneous
smooth muscle tone. Thus, it can be assumed that the observed
diameters reflect the structural diameters as defined above. To
prevent development of tone during the scanning procedure,
papaverine (10−4 mol/l) was continuously superfused.
Observation of the mesentery provided complete datasets
including geometric and flow information for all vessel segments
within the region under consideration. Diameter, length,
hematocrit and blood flow velocity were measured off-line in all
segments (vessel sections between branch points, n = 576) using
a digital image analysis system (Pries et al., 2001). The network
was supplied with blood by a main feeding arteriole (diameter
28µm, blood flow 410 nl/min) and drained by a main venule
(diameter 59µm). Smaller secondary boundary vessels entered (n
= 30) or left (n = 4) the observed region. The two-dimensional
arrangement of vessels in the tissue was reconstructed and
discretized by mapping the network onto a regular hexagonal
(honeycomb) grid with edge length 40µm, resulting in 4,740
vessel elements and 31,379 tissue elements (Reglin et al., 2009).
Model Approach
The experimental data on network structure and hemodynamics
were used as the basis for theoretical simulations of vascular
diameter adaptation of all vessels to hemodynamic andmetabolic
stimuli as described previously (Pries et al., 1998, 2001; Reglin
et al., 2009) and as shown schematically in Figure 2. A more
detailed description is given in the Supplementary Information.
Physiological constants used in this model are given in Table 1.
For each selected metabolic signaling mode, the resulting steady-
state distributions of vessel diameters, hemodynamic parameters
and oxygen levels are predicted using an iterative procedure. The
observed vessel diameters are used as initial diameter estimates.
Experimental data on flow conditions in boundary segments of
the network are used to calculate flow rate, flow velocity, wall
shear stress and discharge hematocrit for all segments (Pries
et al., 1990). Hematocrits are calculated taking into account the
effects of uneven red blood cell flux distribution at microvascular
bifurcations with diverging flows (Pries et al., 1989). The oxygen
distribution in the vessel network and the surrounding tissue
is calculated from the geometry and arrangement of vessel
and tissue elements, and from the blood flow and discharge
hematocrit for each segment (Reglin et al., 2009). The oxygen
level in the main feeding arteriole is assumed to be 95 mmHg. At
each step in the iteration, vessel diameters are updated according
an assumed set of adaptation rules using a model for structural
vessel diameter adaptation (Pries et al., 2001). The adaptation
rules, which are identical for all vessels of the network, prescribe
vascular responses to adaptive stimuli. Increased wall shear stress,
decreased transmural pressure and increased local concentration
of a metabolic signal substance at the vessel wall are assumed
to stimulate increase in vessel diameter. This procedure is
repeated iteratively until a steady state is reached. No limitations
are imposed with respect to maximal or minimal diameters
achievable. Finally, the performance of each metabolic signaling
mode is assessed in terms of the resulting oxygen supply to
the tissue, i.e., the percentage of tissue area exhibiting a PO2 <
1 mmHg (tissue hypoxic fraction), and the deviation between
experimentally measured and predicted flow velocities for all
vessel segments, i.e., the velocity error Verr defined as the root
mean square relative deviation of calculated from measured flow
velocities. Velocity differences are a sensitive parameter since
even small changes of diameters elicit large changes in flow
velocity (Pries et al., 1998).
Three metabolic signaling modes were considered. A
hypothetical signal substance was assumed to be generated in
the vessel wall (vessel signaling), the parenchymal tissue (tissue
signaling) and/or red blood cells (RBC signaling), at a rate that
increases with decreasing oxygen level over a defined range of
values. The production rate in the oxygen-dependent range is
given in arbitrary units by:
Jm = [1− (PO2)/(PO2 ref)]
α
•G•β for PO2 ≤ PO2 ref
Jm = 0 for PO2 > PO2 ref (1)
where PO2 ref is a reference level of oxygen partial pressure. For
RBC signaling, PO2 and PO2 ref are replaced by So2 and So2 ref
in this equation. The parameter α defines the shape of the PO2
dependence of metabolic signal production. The standard value
α = 1 gives linear dependence, and α > 1 (α < 1) gives increased
PO2 sensitivity at low (high) PO2 values.
Reference PO2 values obtained previously by parameter
optimization with the three signaling modes were used: 95
mmHg for vessel signaling, 115 mmHg for tissue signaling, and
92 mmHg, corresponding to SO2 ref = 0.93, for RBC signaling
(Reglin et al., 2009). The quantity G corresponds to the extent
of the signal-producing structures. For tissue signaling, the
volume of a tissue element is used. For RBC signaling, local
tube hematocrit is used. For vessel signaling, several different
measures of vessel extent were tested, as described below. The
constant β is chosen for each mode to achieve the same total
amount of metabolite released per time for all three modes, for
the experimentally observed segment diameters.
The metabolic signal substance reaches the wall and lumen
of vessel segments by diffusion in tissue signaling or is directly
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FIGURE 2 | Schematic outline of modeling approach, indicating data input and assumptions used as input to the model, major steps in the computation, and
resulting outputs. See text and supplement for details.
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TABLE 1 | Standard values of model parameters for oxygen transport and consumption.
Description Value Unit References
BLOOD PARAMETERS
Oxygen binding capacity of RBC 0.52 ml O2 ml
−1 Clark et al., 1985
PO2 at half-maximal hemoglobin saturation 38 mmHg Gray and Steadman, 1964
Hill equation exponent 3 Gray and Steadman, 1964
Solubility of oxygen in RBC 3.38 · 10−5 cm3 O2 cm
−3 mmHg−1 Altman and Dittmer, 1971
Solubility of oxygen in plasma 3 · 10−5 cm3 O2 cm
−3 mmHg−1 Hellums et al., 1996
Krogh diffusion coefficient in plasma 8.3 · 10−10 (cm2 s−1) (cm3 O2 cm
−3 mmHg−1) Hellums et al., 1996
TISSUE PARAMETERS
Oxygen diffusion coefficient 1.04 · 10−5 cm2 s−1 Yaegashi et al., 1996
Solubility of oxygen 3 · 10−5 cm3 O2 cm
−3 mmHg−1 Yaegashi et al., 1996
Krogh diffusion coefficient (Kt = Dt · αt ) 3.12 · 10
−10 (cm2 s−1) (cm3 O2 cm
−3 mmHg−1)
Oxygen demand 0.01 cm3 O2 cm
−3 min−1 Tsai et al., 1998; Golub et al., 2007
PO2 at half-maximal oxygen consumption 1 mmHg Costa et al., 1997; Richmond et al., 1999
Thickness of the mesentery 20 µm Barber et al., 1987
delivered into the flowing blood in vessel and RBC signaling. The
metabolic signal substance entering the segment lumen locally
in each vessel segment is added to the amount of metabolic
signal substance convected from upstream regions, assuming
no decay. In addition to downstream convection, the metabolic
signal information is assumed to be propagated upstream along
vessel walls by vascular conducted responses (Pries et al., 1998,
2001).
Variation of Assumed Metabolic Signaling
Mode
For all assumed metabolic signaling modes, adjustable model
parameters were optimized to minimize the velocity error Verr .
For each parameter setting, the tissue hypoxic fraction was
determined.
The vessel signaling mode served as the reference for
additional analysis, since this mode was previously found to
result in lower velocity errors than tissue and RBC signaling
modes (Reglin et al., 2009). For this mode, several alternatives
for the quantity G in Equation (1) were tested, as follows: (i) no
dependence on geometry or flow (G = 1); (ii) vessel length (G =
L, standard case); (iii) vessel surface area (G = L·D); (iv) vessel
volume (G = L·D2); (v) vessel blood flow (G = D2·v); where L =
vessel length, D= vessel diameter, v= blood flow velocity.
To test the effect of the assumed dependence of metabolic
signal production on oxygen level, two types of dependence
were considered in vessel signaling. (i) Production rate is fixed
for PO2 values below a threshold and decreases linearly with
increasing PO2 above the threshold according to Equation (1).
(ii) Production rate decreases with increasing PO2 below a
threshold and is fixed for PO2 values above the threshold. In each
case, the threshold PO2 ref was varied from 0 to 95 mmHg.
As already mentioned, multiple mechanisms for acute
metabolic flow regulation have been identified, and these may
contribute to structural adaptation of vessel diameters. To test
the effect of combining different modes of metabolic signaling,
the three modes were combined linearly with weighting factors
adding up to 1, so as to maintain the overall strength of metabolic
signaling. Individual weighting factors were systematically
varied in steps of 0.1. The rates of production of metabolic
signal substances by the different modes were determined
and the concentration of signal substance in a given vessel
segment was multiplied with the respective weighting factor.
The summed local concentration was then used to calculate
the metabolic stimulus. Simulations were performed assuming
oxygen dependent production of metabolic signaling (according
to Equation 1) and also with oxygen-independent production
(according to Jm = G β).
RESULTS
Effects of Combining Vessel, Tissue, and
RBC Signaling Modes
The effects of metabolic signaling by combinations of vessel,
tissue and RBC modes on hypoxic fraction and velocity
error are shown in Figure 3. With either oxygen-sensitive
or oxygen-insensitive signaling, hypoxic fractions below 1%
are achieved for all combinations except those dominated by
RBC signaling (Figures 3A,C). Thus, any combination with a
significant component of vessel and/or tissue signaling yields
vessel diameter and blood flow distributions resulting in low
tissue hypoxia levels. Combinations dominated by RBC signaling
also yield high levels of velocity error, Verr (Figure 3B). The
lowest values of velocity error, indicating closest agreement with
experimental results, are obtained with oxygen-sensitive vessel
signaling (Verr = 0.58). When oxygen-insensitive signaling is
assumed, a combination of vessel and tissue signaling gives
the lowest Verr (0.61) (Figure 3D). These results suggest that
the metabolic control of the experimentally observed vascular
structure was governed by an oxygen-sensitive vessel signaling
mode. No other combination of signaling modes gave a lower
Verr . In further simulations, oxygen-sensitive vessel signaling
and RBC signaling were combined with oxygen-insensitive tissue
signaling. The results (Figure S1) differed only slightly for those
with oxygen-sensitive tissue signaling.
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FIGURE 3 | Effect of combining metabolic signaling by vessel signaling, tissue signaling and RBC signaling modes on tissue hypoxic fraction (A,C) and on velocity
error (B,D). The three modes were weighted according to the scheme shown at top, with the weights adding up to 1. (A,B) Results with oxygen dependent
generation of metabolic signal substance. (C,D) Results with oxygen independent generation of metabolic signal substance.
Effects of Signal-Producing Structure
(Vessel Signaling)
Effects of the assumed geometrical dependence of metabolic
signal production (G in Equation 1) on velocity error (Verr)
for vessel signaling are summarized in Figure 4A. Assuming
no dependence of production on geometry or flow (G =
1) in a given vessel segment resulted in Verr = 0.71. The
minimal velocity error (0.59) was obtained assuming production
proportional to vessel length. Signal production proportional
to vessel surface area, vessel volume or vessel blood flow gave
successively higher values of Verr . Tissue hypoxic fraction (data
not shown) exhibited a similar behavior with values of 0.54,
0.24, 0.30, 1.19, and 8.95% for the five cases. Length dependence
was chosen as the standard for vessel signaling for all other
simulations.
Effects of Restricting Range of Oxygen
Sensitivity
The minimal values of Verr and hypoxic fraction were obtained
when the metabolic signal was assumed to be sensitive to PO2
over the entire range from 0 to 95 mmHg. This corresponds to
thresholds of 0 mmHg and 95 mmHg respectively for the two
types of oxygen sensitivity considered. However, in each case,
altering the threshold for oxygen sensitivity resulted in only slight
increases in hypoxic fraction (Figures 4B,D), even when oxygen
sensitivity was eliminated. The computed oxygen distributions
in the tissue with and without oxygen sensitivity are shown in
Figure 5. This unexpected finding that oxygen sensitivity was not
required for effective tissue oxygenation is discussed below. The
velocity error remained low as long as oxygen sensitivity was
retained for PO2 levels above 80 mmHg (Verr 0.61 for a threshold
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FIGURE 4 | Effects of assumed vessel signaling mechanisms on tissue oxygenation and velocity error. (A). Effect of the extent of signal producing structures on
velocity error (Verr ). Changing factor G in equation 1, sensitivity to vessel number (G = 1), length, surface area, volume and flow is modeled. (B,C). Effects of oxygen
sensitivity range in vessel signaling, with sensitivity only above the threshold level up to 95 mmHg (see inset). Effects of threshold PO2 on hypoxic fraction (B) and Verr
(C). (D,E). Effects of oxygen sensitivity range in vessel signaling, with sensitivity only below the threshold PO2 level down to 0 mmHg (see insets). Effects of threshold
PO2 on hypoxic fraction (D) and Verr (E).
PO2 of 80 mmHg), but increased when oxygen sensitivity above
80 mmHg was removed from the model (Figures 4C,E).
Further simulations were performed with combinations of
two signaling modes, where one mode was assumed to exhibit
PO2 sensitivity in a high PO2 range and the other in a low
PO2 range. The results (Figure S2) showed that low velocity
errors are achieved only when wall signaling is included, with
oxygen sensitivity in the upper range of PO2 values. Additional
simulations were performed (data not shown), in which oxygen
sensitivity was assumed to depend on intravascular pressure, wall
shear stress or vessel diameter, or was restricted to arterioles.
Also, the exponent α in Equation (1) was varied from 1 to
between 0.5 and 3. All approaches led to higher Verr levels
compared to standard conditions (α = 1).
DISCUSSION
The goal of the present work is to gain insight into the
mechanisms governing structural responses of microvessel
diameters to metabolic signals. The approach depends on the
assumption that fully adapted inner vessel diameters represent
the outcome of biological mechanisms that control structural
adaptation in response tometabolic and hemodynamic signals, so
as to provide a biologically adequate distribution of blood flow in
the vascular network. Therefore, simulating possible mechanisms
and testing their ability to generate results consistent with
experimental observations allows testing of hypotheses regarding
these mechanisms of adaptation. The simulations of diameter
adaptation are based on microvascular network data derived
Frontiers in Physiology | www.frontiersin.org 7 October 2017 | Volume 8 | Article 813
Reglin et al. Metabolic Control of Microvessel Diameters
FIGURE 5 | Distributions of simulated PO2 in a mesenteric section supplied
by a microvascular network with vessel diameters resulting from simulated
adaptation assuming oxygen sensitivity of vascular adaptation (Top) or no
oxygen sensitivity (Bottom).
from the mesentery, a tissue that does not experience large
changes in metabolic demand over time, and from adult animals.
Therefore, the observed vessel morphology can reasonably be
assumed to represent a fully adapted steady state of the system.
The experimental vasculature studied here did not exhibit
tone during the experiment (Pries et al., 1998), and so vessel
diameters represent solely the result of structural adaptation.
In the presence of tone, arteriolar diameters would reflect the
combined effect of structural (maximally dilated) diameter and
superimposed smooth muscle contraction.
In this study, we assessed different assumed mechanisms
of structural adaptation in terms of two parameters: predicted
hypoxic fraction; and overall deviation between predicted and
observed velocities (Verr). The hypoxic fraction is considered as
a measure of the potential of the assumed mechanism to meet
the functional needs of the tissue for oxygen supply, while Verr
indicates deviation from experimentally observed conditions.
The errors in the experimental measurements of vessel diameters,
flow velocities, etc., and the simplifying assumptions of the
model result in a basic component of Verr which is relatively
large compared to the variations in Verr found with different
assumedmechanisms (Pries et al., 1994). However, the remaining
component of Verr is sensitive to changes in the assumed
adaptive mechanisms, and minimization of Verr may indicate
which mechanisms are likely present in the physiological
system.
In previous work (Reglin et al., 2009), we considered the same
three modes of metabolic control of vascular diameters, namely
vessel signaling, tissue signaling and RBC signaling, each acting
individually, and showed that vessel signaling led to minimal
tissue hypoxia and closest agreement between predicted and
observed vessel flow velocities in individual segments (minimal
Verr). Those results were confirmed in the present study, where
the velocity error was lowest with vessel signaling mode, higher
with tissue signaling mode, and highest with RBC signaling mode
(Figure 3). The previous study did not consider the possibility
that a combination of signaling modes could lead to lower levels
of tissue hypoxia and Verr than could be achieved by any one
mechanism acting alone. The present results show that this
is not the case when oxygen-sensitive signaling is considered
(Figure 3B). In the present study, we also considered cases in
which all three signaling modes are insensitive to oxygen levels.
The results for hypoxic fraction are similar to those with oxygen-
sensitive signaling, in that hypoxic fraction was low with vessel
or tissue signaling but high with RBC signaling (Figure 3C). In
these case, Verr levels were somewhat higher and the minimum
was found for a combination of tissue and vessel signaling
(Figure 3D).
In the present study, we explored the dependence of
vessel signaling on the assumed signal-producing structure, by
considering signals generated in proportion to the number,
length, surface area, volume, or flow rate in each vessel.
While it might be expected that signals are generated in
proportion to vessel surface area (i.e., endothelial cell area),
the best match between model predictions and experimental
data was obtained for vessel signaling in proportion to vessel
length (Figure 4A). Signal generation in proportion to surface
area has the consequence that the signal decreases with
decreasing vessel diameter, which diminishes the ability of
low-flow vessels to restore adequate flow. This may account for
the advantageous behavior of length-dependent signaling. One
possible interpretation of this result is that the signal is generated
from a tissue sleeve of constant outer radius adjacent to the vessel,
such that the volume of signal-generating tissue is proportional to
the vessel length. Such behavior could result from mechanisms
limiting the effective diffusion distance of signaling molecules
such as adenosine (Deussen, 2000), VEGF (Ji et al., 2007) or
HETE (Lombard et al., 1999). This “tissue sleeve” hypothesis
might explain experimental observations where PO2 sensitivity
was lost after complete dissection of perivascular tissue from
arterioles in situ (Jackson, 1987) while being preserved if even
small amounts of perivascular tissue remained in contact with the
vessel (Jackson and Duling, 1983).
The role of oxygen sensitivity in metabolic signaling was
investigated by restricting the range of PO2 values for which
metabolic signals are produced in an oxygen-dependent fashion.
Sensitivity in the high PO2 range was shown to have the greatest
impact in reducing Verr (Figures 5D,E) while varying oxygen
sensitivity at lower PO2 levels had little effect (Figures 5B,C).
Even in the complete absence of oxygen sensitivity, relatively
low velocity errors were obtained with vessel signaling. Thus, the
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results of the present study surprisingly suggest that functionally
adequate vessel diameter distributions can be achieved with
restricted or absent oxygen sensitivity. This finding can be
understood in terms of feedback mechanisms involved in
control of vessel diameters (Figure 6A). Independent of oxygen
sensitivity, negative feedback is provided by the “dilution effect”
(Reglin and Pries, 2014) for signal substances released into the
blood that evoke vessel diameter increase: The concentration in
the blood of a substance that diffuses into the vessel at a given
rate increases inversely with decreasing volume flow rate. In
low flow vessels, the higher substance concentration may thus
evoke a stronger signal for diameter increase, providing a simple
and robust mechanism for adaptation to maintain adequate
flow in all vessels, provided that the existing network structure
provides adequate vessel density. This mechanism may operate
in tissues such as the lung that are not dependent on blood for
oxygen supply. However, mechanisms involving sensitivity to
oxygen must play a key role in enabling adaptation of vascular
networks to short and long term changes in the oxygen supply-to-
demand ratio of the tissue, including stimulation of angiogenesis
to increase vascular density when oxygen demand increases
(Secomb et al., 2013; Reglin and Pries, 2014).
Insight into the possible reasons for this finding can be
obtained by considering the feedback loops involved in each
signaling mode (Figure 6). In vessel signaling, the dilution effect
and PO2-dependent signaling act together to provide robust
negative feedback regulation, with vessel diameter increasing in
response to low flow and low PO2 (Figure 6A). This provides
FIGURE 6 | Feedback loops involved in structural control of structural vessel diameters, under different assumed metabolic signaling modes. Arrows and blunt ends
indicate stimulatory and inhibitory action. Signs “+” and “–” in gray rectangles indicate positive and negative feedback regulation. Upper loop: hemodynamic
feedback. Lower loops: metabolic feedback. In all cases, the growth response to wall shear stress produces a positive hemodynamic feedback loop, which must be
counteracted by negative feedback from metabolic responses to maintain stability. (A) Vessel signaling. Increased blood flow causes increased intravascular PO2
which reduces production of the metabolic signaling substance, resulting in a negative feedback loop (upper metabolic loop). In addition, the dilution effect (lower
metabolic loop) introduces a negative feedback that operates independently of oxygen sensitivity. (B) Tissue signaling. Increased blood flow causes increased
intravascular PO2, and hence increased tissue PO2, which reduces production of the metabolic signaling substance, resulting in a negative feedback loop which,
however will be compromised for situations where the maximal oxygen diffusion distance is exceeded (dashed arrow). The dilution effect is again present. (C) RBC
signaling. Increased blood flow causes increased RBC hemoglobin oxygen saturation, reducing production of the metabolic signaling substance, resulting in a
negative feedback loop (upper metabolic loop). However, decreasing vessel diameter and blood flow decrease the local concentration of RBCs due to unequal RBC
distribution at microvascular bifurcations, and this introduces a destabilizing positive feedback effect (middle metabolic loop). The dilution effect is again present (lower
metabolic loop). (D) Vessel signaling with a vasoconstrictor signaling substance. Increased blood flow causes increased intravascular PO2, which increases
production of the metabolic vasoconstrictor signaling substance, resulting in a negative feedback loop. However, increased blood flow also reduces the concentration
of the metabolic signaling substance in the blood by the dilution effect, which introduces a destabilizing positive feedback.
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a likely explanation for the effectiveness of vessel signaling in
producing low levels of tissue hypoxia and velocity error.
In tissue signaling, the situation is similar to that in
vessel signaling, with both the dilution effect and PO2-based
signaling providing negative feedback regulation (Figure 6B) but
somewhat higher velocity error (Figure 3B). This may be due
to partial decoupling of the feedback, as oxygenation of tissue
cells is determined both by vascular perfusion and diffusion
distance. If vessel density is too low, increase of vascular diameter
caused by metabolic signals released by the tissue cannot lead
to adequate tissue oxygenation if the distance from microvessels
to cells within the tissue exceeds the maximal oxygen diffusion
distance (depending on tissue oxygen consumption). In this
situation, inadequately supplied tissue cells would continue to
produce increased levels of themetabolic signal substance despite
the diameter increase of existing vessels, compromising the
metabolic negative feedback signaling (Reglin et al., 2009).
In RBC signaling, both the dilution effect and the SO2-based
signaling provide negative feedback regulation (Figure 6C).
However, in this case the metabolic substances are generated in
proportion to local tube hematocrit (HT). As a consequence of
the unequal partition of hematocrit in diverging microvascular
bifurcations, vessels with lower flow also tend to receive lower
hematocrit (Pries et al., 1989). This effect reduces the amount
of RBC-derived signal substance in a low-flow vessel, creating
a destabilizing positive feedback loop (Reglin et al., 2009;
Figure 6C). Therefore, RBC signaling provides a less effective
mechanism for ensuring tissue oxygenation, relative to vessel and
tissue signaling. An analogous conclusion was reached in the
context of acute flow regulation (Roy et al., 2012).
Low PO2 was considered to lead to an increased release
of dilator substances in the models discussed so far.
Alternatively, decreasing PO2 could lead to a declining release
of vasoconstrictive mediators, as has been shown for release of
leukotrienes or 20-HETE in vivo (Jackson, 1993; Lombard et al.,
1999). In this case, shown schematically in Figure 6D, an increase
in flow results in a reduced concentration of the vasoconstrictor
by the dilution effect, creating a positive feedback mechanism
that leads to further flow increase and works against uniform
tissue oxygenation. Therefore, it is unlikely that vasoconstrictive
mediators can play a primary role in structural adaptation of
diameters in response to metabolic stimuli.
When comparing different signaling modes, the constants β
that specify the signal strength must be chosen. Here, the values
were chosen to give the same total metabolite release rate for all
three modes. The possibility arises that other assumptions might
lead to different conclusions. For instance a higher value of β
might give improved tissue oxygenation with RBC signaling. In
all cases considered, however, RBC signaling gave relatively high
levels of hypoxia and Verr . It was not possible to reduce Verr to
levels comparable to those found with the vessel or tissue mode
by varying the metabolic feedback strength for RBC signaling
Reglin et al., 2009. This is an expected consequence of the positive
feedback mechanism shown in Figure 6C, which would only be
strengthened by increasing β .
In summary, theoretical models have been developed for
structural control of microvessel diameters by metabolic signals,
and the predictions were compared with in vivo experimental
observations. With this approach, a variety of hypotheses
regarding the underlying mechanisms have been tested. The
results indicate that growth signals generated in the vessel
wall or an adjacent tissue sleeve in response to reduced PO2
are likely to play a dominant role in the metabolic control
of vessel diameters. In this context, oxygen sensitivity in the
high PO2 ranges seems to be especially relevant to achieve
realistic diameter distributions. Growth signals derived from the
entire tissue may also play a role but give results that agree
less well with experimental observations. On the other hand,
such signals presumably play an important role in stimulating
angiogenesis when vascular density is inadequate. In contrast,
RBC signaling results in inadequate oxygen distribution, with
significant fraction (∼5%) of hypoxic tissue. With decreasing
flow, vessel hematocrit decreases as a consequence of unequal
hematocrit partition in diverging bifurcations. The reduction of
the concentration of RBCs releasing metabolic signal substances
creates a positive feedback loop. Also, signaling based on a
vasoconstrictor released at high oxygen levels is unlikely to be
effective as it likewise creates a positive feedback loop. The ability
of blood-borne growth signals generated in response to reduced
oxygen levels to regulate vessel diameters is enhanced by the
dilution effect, which causes a reduction of concentration with
increasing flow, providing a negative feedback mechanism. This
mechanism is effective even if the generation of the metabolic
signal substance is independent of oxygen levels.
These results may suggest new targets for experimental studies
of metabolic control of vessel luminal diameter. Candidate
molecules for metabolic control of diameters are likely to be
produced by or in the close vicinity of the vessel wall. While it is
likely that the generation of these substances is PO2-dependent,
growth signals whose generation has no oxygen sensitivity or a
limited range of sensitivity may contribute to diameter control,
as a consequence of the dilution effect.
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